Atlas Trials

[177Lu]Ludotadipep Treatment in Patients With Metastatic Castration-resistant Prostate Cancer.

Clinical trial NCT04509557 · COMPLETED

Trial details

NCT number
NCT04509557
Sponsor
FutureChem
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer
Start date
2020-10-14
Primary completion
2022-06-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.